SNO Grand Rounds: IDH Mutant Glioma: Pivotal Results and Discussion of the INDIGO Trial

The Neuro-Oncology Academy is pleased to announce the first CME webinar in the SNO Grand Rounds Series, IDH Mutant Glioma: Pivotal Results and Discussion of the INDIGO Trial, an activity provided by the Society for Neuro-Oncology.

The broadcast will be live on September 12, 2023, from 12:00-1:00 pm ET.

CME Credit Available.

 

Registration

Click here to be directed to the Neuro-Oncology Academy to register. The webinar is free for all; please use your SNO username and login to register. If you are having trouble logging in, please contact caroline@soc-neuro-ong.org.

 

Physician Credit Designation

The Society for Neuro-Oncology designates this live activity for a maximum of 1.00 AMA PRA Category 1 Credit™.  Physicians should claim only the credit commensurate with the extent of their participation in the activity.

 

About the Academy and the SNO Grand Rounds Series

The Neuro-Oncology Academy is education brought to you by the Society for Neuro-Oncology. Its mission is to provide quality education in a variety of engaging formats for multi-disciplinary professionals in the field of neuro-oncology. The SNO Grand Rounds Series seeks to address a range of timely and important new findings in the field of neuro-oncology.

 The Society for Neuro-Oncology is accredited by the Accreditation Council for Continuing Medical Education (ACCME) to provide continuing medical education for physicians.

Target Audience

Neuro-oncologists, medical oncologists, neurosurgeons, radiation oncologists, radiologists, neuro-pathologists, physicians/scientists, clinical and laboratory trainees, and allied health professionals.

Learning Objectives

After participating in this CME activity, participants should be able to: 

  • Describe the clinical trial design and objectives of the INDIGO study .
  • Review INDIGO study results including outcomes and toxicity data.
  • Interpret the latest clinical trial study results regarding IDH-mutant gliomas.
Course summary
Available credit: 
  • 1.00 AMA PRA Category 1 Credit™
    This activity has been planned and implemented in accordance with the accreditation requirements and policies of the Accreditation Council for Continuing Medical Education (ACCME) through the Society for Neuro-Oncology. The Society for Neuro-Oncology is accredited by the ACCME to provide continuing medical education for physicians.
  • 1.00 Attendance
Course opens: 
07/26/2023
Course expires: 
10/12/2023
Cost:
$0.00

INDIGO Trial 
Patrick Wen, MD, Dana-Farber Cancer Institute

INDIGO: A Closer Look at the Data 
Martin Van Den Bent, MD, Erasmus MC-Daniel den Hoed Cancer Center

The INDIGO Trial Results: Impact on Clinical Care and Future Directions 
Susan Chang, MD, University of California, San Francisco

Speakers
Patrick Wen, MD, Dana-Farber Cancer Institute
Martin Van Den Bent, MD, Erasmus MC-Daniel den Hoed Cancer Center
Susan Chang, MD, University of California, San Francisco


Moderators
Julie Miller, MD, PhD, Mass General 
Katherine Peters, MD, PhD, Duke University


Neuro-Oncology Academy Leadership
Isabel Arrillaga-Romany, MD, PhD, Scientific Director
Eric Sulman, MD, PhD, Co-Director, Basic and Translational Science
Farshad Nassiri, MD, PhD, Co-Director, SNO Track Leader
Shawn Hervey-Jumper, MD, PhD, Co-Director, Annual Meeting Liaison
Sonia Partap, MD, Co-Director, Pediatric Research
Manish Agi, MD, PhD, Co-Director, Clinical Research
Tracy Batchelor, MD, Ex-Offico
Chas Haynes, JD, Ex-Offico

The Society for Neuro-Oncology is accredited by the Accreditation Council for Continuing Medical Education (ACCME) to provide continuing medical education for physicians.

Available Credit

  • 1.00 AMA PRA Category 1 Credit™
    This activity has been planned and implemented in accordance with the accreditation requirements and policies of the Accreditation Council for Continuing Medical Education (ACCME) through the Society for Neuro-Oncology. The Society for Neuro-Oncology is accredited by the ACCME to provide continuing medical education for physicians.
  • 1.00 Attendance

Price

Cost:
$0.00
Please login or register to take this course.

To register for this webinar, please follow these steps:

  1. If you have a Neuro-Oncology Academy account, select Login. If you do not yet have an account, select Register to create your FREE account. If you are a SNO member, select Login and on the next screen login under the “Society for Neuro-Oncology login.”
  2. Select Take Course. Answer the additional registration questions, then select Take Course.
    1. You will receive a confirmation email from Zoom. These emails will include a calendar invitation to add to your email calendar.
  3. When it is time to join the webinar, a zoom link will be emailed to you. Select Join the webinar. The Zoom Webinar window will pop up and you will see the webinar as you normally would. 
  4. After the webinar, come back to this activity to complete the Post Webinar Survey. You'll be able to download your certificate immediately after the webinar.
  5. We hope that this update makes the webinar viewing and credit claiming processes easier for you! Please don't hesitate to reach out to us at academy@soc-neuro-onc.org with any questions.